Wegovy vs Ozempic in the Philippines: same molecule, different bill

The search that brings people here is "wegovy vs ozempic price philippines", and the honest one-line answer is: same molecule, Wegovy costs more at every matched tier, and the premium is around thirteen percent rather than the doubling this page used to report. Every peso figure below was read from a major drugstore chain and checked on 26 August 2026. The table, then the detail.

Novo Nordisk sells semaglutide under two brands: Ozempic, registered for type 2 diabetes, and Wegovy, registered for weight management. The molecule in the cartridge is identical. What the branding changes is the labeled indication, the dose escalation path, and, in the Philippines, the price and the stock behavior.

The dosing difference is the substantive one. Ozempic pens locally top out at 1.0mg weekly. Wegovy titrates through five tiers to 2.4mg weekly, the dose that produced the 14.9% average weight loss in the STEP 1 trial (NEJM 2021). Whether the extra 1.4mg is worth the extra pesos is a clinical question for a prescriber; what this filing can tell you is exactly what each answer costs.

One pen is four weekly doses on either brand, so these are effectively monthly figures, and all of them were checked on 26 August 2026. Two things fall out. The Wegovy starter pen at ₱9,900 does cost more than any Ozempic pen, but by about ₱1,200 to ₱2,250 rather than the doubling this page previously reported, so the titration months are not the trap they were made out to be. And because Wegovy charges one price across its first three tiers, the cost of climbing the ladder is concentrated entirely in the last two steps. The complete pen-by-pen market picture lives in the Ozempic price filing and the Wegovy price filing.

Ozempic is the most widely listed GLP-1 pen in Philippine retail, carried by Watsons, Rose Pharmacy and Southstar at the same price, but widely listed is not the same as available: Manila Bulletin reported in June 2026 that pharmacies had imposed allocation limits, commonly two pens per dosage per month, with pharmacists screening customers to protect diabetic supply. Wegovy is listed across all five tiers at Watsons and is intermittent in practice, with the 1.7mg tier stocked least of all.

The operational rule that follows: call ahead for either, and treat a published listing as a price rather than a promise of stock. Hospital pharmacies are the dependable Wegovy channel because prescribing endocrinologists write into the in-house queue. Both brands require a prescription at every legitimate counter, Watsons validates it before releasing the order, and PhilHealth covers neither for weight loss. The prescribing decision, on either pen, belongs with a licensed Philippine physician.

Every branded semaglutide price in this filing is quietly benchmarked, by the self-pay market, against research-grade semaglutide: 5mg vials at ₱2,800 to 4,500 that cover a month or more at maintenance doses. Against the cheapest Ozempic pen at ₱7,650 that is a gap of roughly two to three times, not the fivefold gap this page previously claimed, and it narrows again once consult fees, supplies, bloodwork and cold-chain shipping are counted. What the vial does not include: the pharma pen format, registered-pharmacy dispensing, audited cold chain, or anyone's oversight but your own, which means batch COA verification, cold-chain packaging, and baseline labs are on you.